Physician profile
Mark D Hurwitz
NPI 1891751046
$30,262.89
in general payments reported to CMS, 2019-2025
7 companies · $2,489 in 2025
The $2,489 reported for 2025 was more than what 91% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,271 · 2022: $20K · 2023: $943 · 2024: $2,916 · 2025: $2,489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,104 · Food and Beverage: $2,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,104.00 |
| Food and Beverage | $2,243.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24,830.00 | 2021-2025 | Clinical Trial Product |
| Reflexion Medical, INC. | $2,979.05 | 2021-2024 | Reflexion Medical Radiotherapy System |
| Zap Surgical Systems, INC. | $1,192.77 | 2021-2025 | Zap-X Treatment Planning Software, Zap-X Treatment Delivery Software, Zap-X Radiosurgery System |
| Gt Medical Technologies, INC | $890.54 | 2023-2025 | Gammatile, Gammatile |
| Siemens Medical Solutions USA, INC. | $216.38 | 2023-2025 | Bravos Afterloader System |
| Genentech USA, INC. | $154.15 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hurwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.